Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis
Background: Coronavirus disease 2019 (COVID-19) has spread globally, and many patients with severe cases have received oxygen therapy through a high-flow nasal cannula (HFNC). Objectives: We assessed the efficacy of HFNC for treating patients with COVID-19 and risk factors for HFNC failure. Methods:...
Main Authors: | Dong-yang Xu, Bing Dai, Wei Tan, Hong-wen Zhao, Wei Wang, Jian Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-04-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/17534666221091931 |
Similar Items
-
Comparison between high-flow nasal cannula and noninvasive ventilation in COVID-19 patients: a systematic review and meta-analysis
by: Yun Peng, et al.
Published: (2022-07-01) -
Comparison between high-flow nasal cannula and conventional oxygen therapy in COVID-19 patients: a systematic review and meta-analysis
by: Jian-chao Wang, et al.
Published: (2024-01-01) -
Use of high-flow nasal cannula oxygen and risk factors for high-flow nasal cannula oxygen failure in critically-ill patients with COVID-19
by: Zakaria Ait Hamou, et al.
Published: (2022-12-01) -
High-flow nasal cannula for respiratory failure in adult patients
by: SeungYong Park
Published: (2021-11-01) -
Nasal high flow cannula maybe prioritized in treating patients suffering from COVID-19?
by: Yung-Chia Huang, et al.
Published: (2021-11-01)